Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lilly, Merck and Pfizer form Asian Cancer Research Group

Feb. 23, 2010

Viamet and Novartis partner for metalloenzyme inhibitors

Feb. 23, 2010

Ceragenix and BexPharm enter into agreement for EpiCeram

Feb. 23, 2010

Chugai licenses Roche's Hedgehog pathway inhibitor RG-3616 in Japan

Feb. 19, 2010

Thallion and LFB sign agreement to develop STEC infection therapy

Feb. 19, 2010

SurModics to terminate license agreement with Ambrilia Biopharma

Feb. 19, 2010

Paladin amends R&D agreement with Isotechnika for diagnostic products

Feb. 19, 2010

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics

Feb. 18, 2010

MorphoSys and Galapagos add another antibody target to alliance in bone and joint diseases

Feb. 18, 2010

Lung Rx and ImmuneWorks sign development agreement for IW-001 in IPF and PGD

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...